tHEORetically Speaking
Insights, observations, and executive interviews that discuss data and evidence to guide value-based decisions in health care. For more, visit our blog: https://healtheconomics.com/theoretically-speaking/
tHEORetically Speaking
INsights & OUTcomes with Matt McLoughlin
This episode features Matt McLoughlin, Senior Vice President of Compliance and Categories at Scientist.com. With 25 years in pharma R&D and Procurement, Matt has enhanced outsourcing for biopharma companies, focusing on speed, efficiency, and compliance. His expertise in regulated industries extends to RWE, HEOR, and Market Access, transforming access to external services to boost innovation while cutting costs and project timelines.
To stay connected with us, visit our LinkedIn page and subscribe to our newsletter!
Learn more about Scientist.com and how they can help with planning your book of work here: https://www.healtheconomics.com/5-key-questions-to-ask-before-you-launch-a-value-evidence-plan
Introducing Trial Insights—the essential tool for pharma researchers and biotech investors.
Seamlessly track clinical trials in real-time, refine searches by key criteria, and receive timely notifications on important updates. With Trial Insights, ensure your research and business initiatives are always informed and strategically positioned for success.
Start exploring thousands of trials today at trialinsights.com